AYTU
Aytu BioScience Inc
NASDAQ: AYTU · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.58
+2.38% today
Updated 2026-04-30
Market cap
$27.05M
P/E ratio
—
P/S ratio
0.43x
EPS (TTM)
$-3.44
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
Aytu BioScience Inc (AYTU) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1750.00 | — | — | $1750.00 | $1750.00 | $58929.00 | $261782.00 | $2.56M | $3.22M | $3.66M | $7.32M | $27.63M | $65.63M | $96.67M | $107.40M | $65.18M | $66.38M |
| Revenue growth (YoY) | — | — | — | -100.0% | — | — | +0.0% | +3267.4% | +344.2% | +878.8% | +25.7% | +13.6% | +100.0% | +277.5% | +137.5% | +47.3% | +11.1% | -39.3% | +1.8% |
| Cost of revenue | — | — | — | — | — | — | $-48250.00 | $6.31M | $88109.00 | $957076.00 | $1.42M | $2.05M | $2.20M | $8.28M | $36.43M | $46.39M | $40.77M | $16.13M | $20.55M |
| Gross profit | — | — | $1750.00 | — | — | $1750.00 | $50000.00 | $58929.00 | $173673.00 | $1.61M | $1.80M | $1.61M | $5.12M | $19.35M | $29.20M | $50.28M | $66.63M | $49.05M | $45.83M |
| Gross margin | — | — | 100.0% | — | — | 100.0% | 2857.1% | 100.0% | 66.3% | 62.6% | 56.0% | 44.0% | 69.9% | 70.0% | 44.5% | 52.0% | 62.0% | 75.3% | 69.0% |
| R&D | — | — | — | — | — | — | $2.76M | $4.06M | $3.42M | $6.32M | $1.35M | $167595.00 | $589072.00 | $1.72M | $5.62M | $12.66M | $4.09M | $2.77M | $1.33M |
| SG&A | $46890.00 | $54984.00 | $54862.00 | $54161.00 | $129369.00 | $58106.00 | $47984.00 | $2.35M | $4.38M | $8.83M | $17.61M | $17.73M | $19.24M | $19.66M | $25.50M | $31.17M | $28.63M | $19.95M | $17.38M |
| Operating income | $-46890.00 | $-54984.00 | $-55822.00 | $-56741.00 | $-133619.00 | $-56356.00 | $-52414.00 | $-6.35M | $-7.63M | $-21.70M | $-20.13M | $-19.70M | $-16.85M | $-21.13M | $-58.87M | $-109.91M | $-17.07M | $-1.59M | $-7.83M |
| Operating margin | — | — | -3189.8% | — | — | -3220.3% | -2995.1% | -10770.3% | -2915.5% | -847.0% | -624.7% | -538.3% | -230.1% | -76.5% | -89.7% | -113.7% | -15.9% | -2.4% | -11.8% |
| EBITDA | $-40470.00 | $-47469.00 | $-47539.00 | $-47282.00 | $-126856.00 | $-50206.00 | $-47472.00 | $-52709.00 | $-7.51M | $-21.81M | $-18.13M | $-15.25M | $-14.61M | $-12.21M | $-29.04M | $-27.96M | $-3.27M | $1.41M | $-4.67M |
| EBITDA margin | — | — | -2716.5% | — | — | -2868.9% | -2712.7% | -89.4% | -2870.4% | -851.3% | -562.8% | -416.7% | -199.6% | -44.2% | -44.2% | -28.9% | -3.0% | 2.2% | -7.0% |
| EBIT | $-46890.00 | $-54984.00 | $-55822.00 | $-56467.00 | $-133619.00 | $-56356.00 | $-52414.00 | $-150185.00 | $-7.63M | $-22.69M | $-19.97M | $-17.10M | $-16.85M | $-17.92M | $-38.24M | $-38.10M | $-12.09M | $-5.32M | $-10.04M |
| Interest expense | $2064.00 | $0.00 | $3072.00 | $3803.00 | $3183.00 | $3319.00 | $4904.00 | $4234.00 | $114994.00 | $5.49M | $2.53M | $749423.00 | $0.00 | $0.00 | $37.53M | $147.50M | $4.96M | $4.79M | $3.70M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-48954.00 | $-57173.00 | $-58894.00 | $-60270.00 | $-136802.00 | $-59675.00 | $-57318.00 | $-5.58M | $-7.72M | $-28.18M | $-22.51M | $-10.19M | $-47.17M | $-13.62M | $-58.29M | $-108.78M | $-17.05M | $-15.84M | $-13.56M |
| Net income growth (YoY) | — | -16.8% | -3.0% | -2.3% | -127.0% | +56.4% | +3.9% | -9632.9% | -38.4% | -264.9% | +20.1% | +54.7% | -363.0% | +71.1% | -327.9% | -86.6% | +84.3% | +7.1% | +14.4% |
| Profit margin | — | — | -3365.4% | — | — | -3410.0% | -3275.3% | -9466.8% | -2950.3% | -1099.7% | -698.7% | -278.4% | -644.3% | -49.3% | -88.8% | -112.5% | -15.9% | -24.3% | -20.4% |